Peter Wohlfahrt MD, PhD , Dominik Jenča MD , Vojtěch Melenovský MD, PhD , Jolana Mrázková Mgr , Marek Šramko MD, PhD , Martin Kotrč MD , Michael Želízko MD , Věra Adámková MD, PhD , Francisco Lopez-Jimenez MD, MSc, MBA , Jan Piťha MD, PhD , Josef Kautzner MD, PhD
{"title":"心肌梗塞后基于远程智能设备的心脏康复:智能康复试点随机交叉研究","authors":"Peter Wohlfahrt MD, PhD , Dominik Jenča MD , Vojtěch Melenovský MD, PhD , Jolana Mrázková Mgr , Marek Šramko MD, PhD , Martin Kotrč MD , Michael Želízko MD , Věra Adámková MD, PhD , Francisco Lopez-Jimenez MD, MSc, MBA , Jan Piťha MD, PhD , Josef Kautzner MD, PhD","doi":"10.1016/j.mcpdig.2024.06.001","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>To evaluate the effect of smart device-based telerehabilitation on V<span>o</span><sub>2peak</sub> in patients after myocardial infarction.</p></div><div><h3>Patients and Methods</h3><p>This was a pilot, single-center, randomized, cross-over study with a 3-month intervention. One month after myocardial infarction, patients had cardiopulmonary exercise testing and a 6-minute walking test (6MWT) and were randomly assigned 1:1. In the intervention group, patients received a smartwatch to track the recommended number of steps, which was individualized and derived from the 6MWT. A study nurse telemonitored adherence to the recommended number of steps a day. In the control group, 150 minutes a week of moderate-intensity physical activity was recommended. After 3 months study arms were crossed over, and study procedures were repeated after 3 months.</p></div><div><h3>Results</h3><p>Between June 1, 2019, and February 28, 2023, 64 patients were randomized, of which 61 (aged 51±10 years, 10% women) completed the study. Overall, the smart device-based telerehabilitation led to 2.31 mL/kg/min (95% CI, 1.25-3.37; <em>P</em><.001) V<span>o</span><sub>2peak</sub> increase compared with the control treatment. Furthermore, there was a significant effect on weight (−1.50 kg; 95% CI, −0.39 to −2.70), whereas the effect on the 6MWT distance (4.7 m; 95% CI, −11.8 to 21.1) or Kansas City Quality of Life questionnaire score (0.98; 95% CI, −1.38 to 3.35) was not significant.</p></div><div><h3>Conclusion</h3><p>Smart device-based cardiac rehabilitation may be a promising alternative for patients unable or unwilling to attend in-person cardiac rehabilitation.</p></div><div><h3>Trial Registration</h3><p><span>clinicaltrials.gov</span><svg><path></path></svg> Identifier: <span>NCT03926312</span><svg><path></path></svg></p></div>","PeriodicalId":74127,"journal":{"name":"Mayo Clinic Proceedings. Digital health","volume":"2 3","pages":"Pages 352-360"},"PeriodicalIF":0.0000,"publicationDate":"2024-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949761224000622/pdfft?md5=525707d1f0d92a2cc407d45c17140fef&pid=1-s2.0-S2949761224000622-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Remote, Smart Device-Based Cardiac Rehabilitation After Myocardial Infarction: A Pilot, Randomized Cross-Over SmartRehab Study\",\"authors\":\"Peter Wohlfahrt MD, PhD , Dominik Jenča MD , Vojtěch Melenovský MD, PhD , Jolana Mrázková Mgr , Marek Šramko MD, PhD , Martin Kotrč MD , Michael Želízko MD , Věra Adámková MD, PhD , Francisco Lopez-Jimenez MD, MSc, MBA , Jan Piťha MD, PhD , Josef Kautzner MD, PhD\",\"doi\":\"10.1016/j.mcpdig.2024.06.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><p>To evaluate the effect of smart device-based telerehabilitation on V<span>o</span><sub>2peak</sub> in patients after myocardial infarction.</p></div><div><h3>Patients and Methods</h3><p>This was a pilot, single-center, randomized, cross-over study with a 3-month intervention. One month after myocardial infarction, patients had cardiopulmonary exercise testing and a 6-minute walking test (6MWT) and were randomly assigned 1:1. In the intervention group, patients received a smartwatch to track the recommended number of steps, which was individualized and derived from the 6MWT. A study nurse telemonitored adherence to the recommended number of steps a day. In the control group, 150 minutes a week of moderate-intensity physical activity was recommended. After 3 months study arms were crossed over, and study procedures were repeated after 3 months.</p></div><div><h3>Results</h3><p>Between June 1, 2019, and February 28, 2023, 64 patients were randomized, of which 61 (aged 51±10 years, 10% women) completed the study. Overall, the smart device-based telerehabilitation led to 2.31 mL/kg/min (95% CI, 1.25-3.37; <em>P</em><.001) V<span>o</span><sub>2peak</sub> increase compared with the control treatment. Furthermore, there was a significant effect on weight (−1.50 kg; 95% CI, −0.39 to −2.70), whereas the effect on the 6MWT distance (4.7 m; 95% CI, −11.8 to 21.1) or Kansas City Quality of Life questionnaire score (0.98; 95% CI, −1.38 to 3.35) was not significant.</p></div><div><h3>Conclusion</h3><p>Smart device-based cardiac rehabilitation may be a promising alternative for patients unable or unwilling to attend in-person cardiac rehabilitation.</p></div><div><h3>Trial Registration</h3><p><span>clinicaltrials.gov</span><svg><path></path></svg> Identifier: <span>NCT03926312</span><svg><path></path></svg></p></div>\",\"PeriodicalId\":74127,\"journal\":{\"name\":\"Mayo Clinic Proceedings. Digital health\",\"volume\":\"2 3\",\"pages\":\"Pages 352-360\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-06-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2949761224000622/pdfft?md5=525707d1f0d92a2cc407d45c17140fef&pid=1-s2.0-S2949761224000622-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Mayo Clinic Proceedings. Digital health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2949761224000622\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mayo Clinic Proceedings. Digital health","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949761224000622","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Remote, Smart Device-Based Cardiac Rehabilitation After Myocardial Infarction: A Pilot, Randomized Cross-Over SmartRehab Study
Objective
To evaluate the effect of smart device-based telerehabilitation on Vo2peak in patients after myocardial infarction.
Patients and Methods
This was a pilot, single-center, randomized, cross-over study with a 3-month intervention. One month after myocardial infarction, patients had cardiopulmonary exercise testing and a 6-minute walking test (6MWT) and were randomly assigned 1:1. In the intervention group, patients received a smartwatch to track the recommended number of steps, which was individualized and derived from the 6MWT. A study nurse telemonitored adherence to the recommended number of steps a day. In the control group, 150 minutes a week of moderate-intensity physical activity was recommended. After 3 months study arms were crossed over, and study procedures were repeated after 3 months.
Results
Between June 1, 2019, and February 28, 2023, 64 patients were randomized, of which 61 (aged 51±10 years, 10% women) completed the study. Overall, the smart device-based telerehabilitation led to 2.31 mL/kg/min (95% CI, 1.25-3.37; P<.001) Vo2peak increase compared with the control treatment. Furthermore, there was a significant effect on weight (−1.50 kg; 95% CI, −0.39 to −2.70), whereas the effect on the 6MWT distance (4.7 m; 95% CI, −11.8 to 21.1) or Kansas City Quality of Life questionnaire score (0.98; 95% CI, −1.38 to 3.35) was not significant.
Conclusion
Smart device-based cardiac rehabilitation may be a promising alternative for patients unable or unwilling to attend in-person cardiac rehabilitation.